Items tagged with Access
Appeal to develop VXc-486 for tuberculosis (post with simple image)
Advocates urge Vertex to assure the timely and responsible development of drug candidate VXc-486 for tuberculosis.
Urgent need to scale up access to new treatment options for MDR-TB in the Philippines (post with simple image)
Given the urgent need to address the MDR-TB epidemic in the Philippines, advocates urge for rapid delivery of the new treatment options to people with MDR-TB.
Compassionate and optimum use of new tuberculosis drugs (post with simple image)
A report about a patient with the most resistant strain of tuberculosis documented in the USA whose inability to access combination bedaquiline and delamanid compromised his care and created a public health risk.
Life-saving drug stopped by sole supplier (post with simple image)
South Africa is running out of an essential medicine for treating very sick patients with tuberculosis (TB) and drug-resistant bacterial infections. Many hospitals are already out of stock.
Improving regulatory systems to address global TB drug access failures (post with simple image)
Worldwide inefficiencies in drug approval processes are proving disastrous for people living with TB and other diseases.
The FDA’s concession conundrum (post with simple image)
Can regulatory incentives promote responsible TB drug development?
HAI and MSF report shows European Commission’s access to medicines commitments are ‘empty gestures’ (post with simple image)
NGOs urge Commission to align trade, health, research and development policies in comprehensive access to medicines strategy
Newest MDR-TB drug prices could fall by up to 95% through generic production (post with simple image)
The cost of newer drugs for the treatment of multidrug-resistant tuberculosis could be cut by up to 95% if generic production of patented products could be achieved in the same way as for antiretroviral drugs.
WIPO, WTO, WHO heads underline need for better access to medicines (post with simple image)
October 28, 2015 - Trade, health, and intellectual property came together today as the heads of three specialised international organisations held an annual symposium to stimulate discussions on how the three can best help public health, and notably access to medicines in developing countries.
Intravenous rifampicin reintroduced in South Africa (post with simple image)
Equity Pharmaceuticals is the new supplier of the drug.
Page 62 of 83 · Total posts: 0
←First 61 62 63 Last→